Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to buy Pacific Biosciences of California stock

Learn how to easily invest in Pacific Biosciences of California stock.

Pacific Biosciences of California is a medical devices business based in the US. Pacific Biosciences of California shares (PACB) are listed on the NASDAQ and all prices are listed in US Dollars. Pacific Biosciences of California employs 769 staff and has a trailing 12-month revenue of around $146.1 million.

How to buy Pacific Biosciences of California stock

  1. Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – PACB. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Promoted for low fees

Finder Award

SoFi Invest

  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 in stock when you fund a new account within 30 days

Promoted for social trading

Finder Award


  • Easy to use platform with $0 stock trading & no annual fees
  • Social trading allows you to copy popular portfolios
  • FINDER EXCLUSIVE: Guaranteed $15 bonus when you sign up and deposit $100

Promoted for active trading


  • $0 commissions on stocks and ETFs
  • $0 closing commissions on stock and ETF options
  • Get $100 - $2,000 when you open and fund an account with $5,000 to $100,000+

Pacific Biosciences of California stock price (NASDAQ: PACB)

Use our graph to track the performance of PACB stocks over time.

Pacific Biosciences of California shares at a glance

Information last updated 2023-09-26.
Latest market close$8.46
52-week range$4.97 - $14.55
50-day moving average $11.36
200-day moving average $11.04
Wall St. target price$15.58
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-1.28

Buy Pacific Biosciences of California stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 7 of 7
Name Product Ratings Available asset types Minimum deposit Signup bonus
SoFi Invest
Finder Rating: 4.6 / 5: ★★★★★

Finder Award
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
Get up to $1,000 in stock
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
Finder Rating: 4.2 / 5: ★★★★★

Finder Award
Stocks, Options, ETFs, Cryptocurrency
FINDER EXCLUSIVE: Get a guaranteed $15 bonus
when you sign up and deposit $100
Winner of Finder’s Best Broker for Beginners award. Not available in NY, NV, MN, TN, and HI.
Finder Rating: 4.1 / 5: ★★★★★
Stocks, Options, ETFs, Cryptocurrency, Futures
Get $100 - $2,000
when you you open and fund an account with $5,000 to $100,000+
Highly commended for Best Derivatives Trading Platform award.
Finder Rating: 4 / 5: ★★★★★
Stocks, ETFs, Cryptocurrency, Art, Treasury Bills, Collectibles
Get up to $300 in either stocks or crypto
when you use code FINDERUS to sign up and fund a new account.
2.5% fee applies to all alternative asset transactions.
Finder Rating: 4.2 / 5: ★★★★★
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 4.9% interest on uninvested cash in your account with Robinhood Gold.
JPMorgan Self-Directed Investing
Finder Rating: 4 / 5: ★★★★★
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs, Treasury Bills
Get $50 - $700
when you open and fund an account with $5,000 - $250,000+
Pay no commissions on stocks, ETFs, mutual funds and options.
Finder Rating: 4 / 5: ★★★★★
Stocks, ETFs
Wealthfront builds a free financial plan for the life you want and automate your investments at a low cost.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Is it a good time to buy Pacific Biosciences of California stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Pacific Biosciences of California price performance over time

Historical closes compared with the close of $8.46 from 2023-09-25

1 week (2023-09-20) -10.29%
1 month (2023-08-25) -14.72%
3 months (2023-06-27) -31.83%
6 months (2023-03-24) -11.97%
1 year (2022-09-23) N/A
2 years (2021-09-27) -67.60%
3 years (2020-09-25) 9.25
5 years (2018-09-27) 52.43%

Pacific Biosciences of California financials

Revenue TTM $146.1 million
Gross profit TTM $53.5 million
Return on assets TTM -10.05%
Return on equity TTM -48.22%
Profit margin -218.43%
Book value $2.56
Market Capitalization $2.1 billion

TTM: trailing 12 months

Pacific Biosciences of California share dividends

We're not expecting Pacific Biosciences of California to pay a dividend over the next 12 months.

Pacific Biosciences of California share price volatility

Over the last 12 months, Pacific Biosciences of California's shares have ranged in value from as little as $4.97 up to $14.55. A popular way to gauge a stock's volatility is its "beta".

PACB.US volatility(beta: 1.64)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Pacific Biosciences of California's is 1.6411. This would suggest that Pacific Biosciences of California's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Pacific Biosciences of California overview

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits designed for specific workflow, such as template preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. The company serves research institutions; commercial laboratories; genome centers; public health labs, hospitals and clinical research institutes, contract research organizations, and academic institutions; pharmaceutical companies; and agricultural companies. It markets its products through a direct sales force in North America and Europe, as well as through distribution partners in Asia, Europe, the Middle East, Africa, and Latin America. It has a development and commercialization agreement with Invitae Corporation; and a collaboration with Radboud University Medical to explore genetic causes of rare and genetic diseases.

Frequently asked questions

What percentage of Pacific Biosciences of California is owned by insiders or institutions?
Currently 1.719% of Pacific Biosciences of California shares are held by insiders and 96.98% by institutions.
How many people work for Pacific Biosciences of California?
Latest data suggests 769 work at Pacific Biosciences of California.
When does the fiscal year end for Pacific Biosciences of California?
Pacific Biosciences of California's fiscal year ends in December.
Where is Pacific Biosciences of California based?
Pacific Biosciences of California's address is: 1305 O?Brien Drive, Menlo Park, CA, United States, 94025
What is Pacific Biosciences of California's ISIN number?
Pacific Biosciences of California's international securities identification number is: US69404D1081
What is Pacific Biosciences of California's CUSIP number?
Pacific Biosciences of California's Committee on Uniform Securities Identification Procedures number is: 69404D108

More guides on Finder

Ask an Expert provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site